132 related articles for article (PubMed ID: 34696438)
1. Serum microRNA-16 as a potential biomarker for HCV-induced hepato-cellular carcinoma in Egyptian patients.
El Hawary AT; Nabil F; El Hendawy R; Mahrous HKA; AbdelHamid GA; Amer M
Egypt J Immunol; 2024 Apr; 31(2):102-111. PubMed ID: 38615267
[TBL] [Abstract][Full Text] [Related]
2. Study of some potential biomarkers in Egyptian hepatitis C virus patients in relation to liver disease progression and HCC.
Baraka K; Abozahra RR; Badr E; Abdelhamid SM
BMC Cancer; 2023 Oct; 23(1):938. PubMed ID: 37798688
[TBL] [Abstract][Full Text] [Related]
3. Serum angiopoietin-2 levels predict the development of hepatocellular carcinoma following hepatitis C virus eradication using direct-acting antiviral agents.
Suzuki T; Matsuura K; Nagura Y; Kawamura H; Fujiwara K; Ogawa S; Nagaoka K; Iio E; Watanabe T; Kataoka H; Tanaka Y
Oncology; 2024 Jan; ():. PubMed ID: 38211572
[TBL] [Abstract][Full Text] [Related]
4. Characterization of circulating miRNAs in the treatment of primary liver tumors.
Umezu T; Tanaka S; Kubo S; Enomoto M; Tamori A; Ochiya T; Taguchi YH; Kuroda M; Murakami Y
Cancer Rep (Hoboken); 2024 Feb; 7(2):e1964. PubMed ID: 38146079
[TBL] [Abstract][Full Text] [Related]
5. DAAs Rapidly Reduce Inflammation but Increase Serum VEGF Level: A Rationale for Tumor Risk during Anti-HCV Treatment.
Villani R; Facciorusso A; Bellanti F; Tamborra R; Piscazzi A; Landriscina M; Vendemiale G; Serviddio G
PLoS One; 2016; 11(12):e0167934. PubMed ID: 27997563
[TBL] [Abstract][Full Text] [Related]
6. Investigating the effect of polymerase inhibitors on cellular proliferation: Computational studies, cytotoxicity, CDK1 inhibitory potential, and LC-MS/MS cancer cell entrapment assays.
Farouk F; Ibrahim IM; Sherif S; Abdelhamed HG; Sharaky M; Al-Karmalawy AA
Chem Biol Drug Des; 2024 Mar; 103(3):e14500. PubMed ID: 38467555
[TBL] [Abstract][Full Text] [Related]
7. Serum Levels of Interleukin-6 and Interleukin-10 as Biomarkers for Hepatocellular Carcinoma in Egyptian Patients.
Othman MS; Aref AM; Mohamed AA; Ibrahim WA
ISRN Hepatol; 2013; 2013():412317. PubMed ID: 27335826
[TBL] [Abstract][Full Text] [Related]
8. Special Issue: Host Cell-Virus Interaction.
Mukherjee A; Bagchi P
Viruses; 2022 Mar; 14(3):. PubMed ID: 35337022
[TBL] [Abstract][Full Text] [Related]
9. The impact of the revolution in hepatitis C treatment on hepatocellular carcinoma.
Wirth TC; Manns MP
Ann Oncol; 2016 Aug; 27(8):1467-74. PubMed ID: 27226385
[TBL] [Abstract][Full Text] [Related]
10. The impact of treatment of hepatitis C with DAAs on the occurrence of HCC.
Roche B; Coilly A; Duclos-Vallee JC; Samuel D
Liver Int; 2018 Feb; 38 Suppl 1():139-145. PubMed ID: 29427487
[TBL] [Abstract][Full Text] [Related]
11. Role of Serum Vitamin D, Interleukin 13, and microRNA-135a in Hepatocellular Carcinoma and Treatment Failure in Egyptian HCV-Infected Patients Receiving Direct Antiviral Agents.
Ali ME; Halby HM; Ali MY; Hassan EA; El-Mokhtar MA; Sayed IM; Thabet MM; Fouad M; El-Ashmawy AM; Mahran ZG
Viruses; 2021 Oct; 13(10):. PubMed ID: 34696438
[TBL] [Abstract][Full Text] [Related]
12. Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients.
Cabibbo G; Celsa C; Calvaruso V; Petta S; Cacciola I; Cannavò MR; Madonia S; Rossi M; Magro B; Rini F; Distefano M; Larocca L; Prestileo T; Malizia G; Bertino G; Benanti F; Licata A; Scalisi I; Mazzola G; Di Rosolini MA; Alaimo G; Averna A; Cartabellotta F; Alessi N; Guastella S; Russello M; Scifo G; Squadrito G; Raimondo G; Trevisani F; Craxì A; Di Marco V; Cammà C;
J Hepatol; 2019 Aug; 71(2):265-273. PubMed ID: 30959157
[TBL] [Abstract][Full Text] [Related]
13. Enhanced immune responses, PI3K/AKT and JAK/STAT signaling pathways following hepatitis C virus eradication by direct-acting antiviral therapy among Egyptian patients: a case control study.
Ramadan HK; Badr G; Ramadan NK; Sayed A
Pathog Dis; 2021 Mar; 79(3):. PubMed ID: 33524139
[TBL] [Abstract][Full Text] [Related]
14. The influence of direct-acting antivirals in hepatitis C virus related hepatocellular carcinoma after curative treatment.
Kuo YH; Wang JH; Chang KC; Hung CH; Lu SN; Hu TH; Yen YH; Kee KM; Chen CH
Invest New Drugs; 2020 Feb; 38(1):202-210. PubMed ID: 31701431
[TBL] [Abstract][Full Text] [Related]
15. Levels of Cytokines in Serum Associate With Development of Hepatocellular Carcinoma in Patients With HCV Infection Treated With Direct-Acting Antivirals.
Debes JD; van Tilborg M; Groothuismink ZMA; Hansen BE; Schulze Zur Wiesch J; von Felden J; de Knegt RJ; Boonstra A
Gastroenterology; 2018 Feb; 154(3):515-517.e3. PubMed ID: 29102620
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
